⌘K

Login Start Free

Home/Filings/4/0001013762-09-000334

4//SEC Filing

Urigen Pharmaceuticals, Inc. 4

Accession 0001013762-09-000334

CIK 0000932352operating

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 11:52 AM ET

Size

7.7 KB

Accession

0001013762-09-000334

Insider Transaction Report

Form 4

Period: 2009-02-25

Urigen Pharmaceuticals, Inc.UGRP.OB

Parsons C. Lowell

Director

Transactions

Purchase
Common Stock $.001 Par Value
2009-02-25$0.10/sh+5,000$500→ 1,847,693 total
Purchase
Common Stock $.001 Par Value
2009-02-26$0.10/sh+10,000$1,000→ 1,857,693 total
Purchase
Common Stock $.001 Par Value
2009-02-27$0.10/sh+5,000$500→ 1,862,693 total

Documents

1 file

4
mar22009form4parsons_ex.xmlPrimary

Issuer

Urigen Pharmaceuticals, Inc.

CIK 0000932352

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000932352

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 11:52 AM ET
Size: 7.7 KB

View on SEC.gov